Skip to content

Effect of Intraperitoneal Nebulisation of Magnesium Sulphate for Analgesia Following Laparoscopic Cholecystectomy

Phase IV Recruiting

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01542697
Enrollment
60
Registered
2012-03-02
Start date
2011-06-30
Completion date
2012-06-30
Last updated
2012-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain

Keywords

magnesium sulpahate, postoperative analgesia

Brief summary

intraperitoneal nebulisation with magnesuim sulphate will reduce post operative pain and analgesic consumption in postoperative period following laparoscopic cholecystectomy.

Detailed description

Sixty patients undergoing laparoscopic cholecystectomy belonging to American Society of Anaesthesiologist (I-II) of age 18-65 yrs will be enrolled.Group one (n=30) will receive 1.5 gm magnesium sulphate diluted in 3ml of normal saline and group 2 (n=30) will receive 5 ml of NS.

Interventions

DRUGintraperitoneal nebulisation of magnesium sulphate

intraperitoneal nebulisation of 1.5 gm of magnesium sulphate with 2 ml of normal saline

Sponsors

B.P. Koirala Institute of Health Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

ASA I-II \-

Exclusion criteria

history of \-

Design outcomes

Primary

MeasureTime frameDescription
number of analgesic request24 hourtime to first analgesic request is taken as duration of effective analgesia number of analgesic request in first 24 hours were also counted

Secondary

MeasureTime frameDescription
VAS scorefirst complaint of pain, 6 hrs, 12 hrs, 24 hrsVisual analogue scale is a linear 10cm scale with 0 corresponding to no pain and 10 to worst pain ever
nausea and vomiting24 hrs
respiratory rate24 hrs
sedation24hrs

Countries

Nepal

Contacts

Primary ContactSujata Niroula, MD
drsujataniroula@gmail.com00977-9842108624
Backup Contactkrishna Pokharel, MD
drkrishnapokharel@gmail.com00977-9841986321

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026